Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.
Also called NCT04507178
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 100 participants
- Registry
-
NCT04507178
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Netherlands
- Registry status
- Recruiting
Technical summary
Registry record NCT04507178. Randomized; single masking; primary purpose prevention. Start 2022-02-02 (actual); primary completion 2026-08-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine
- Acronym
- ISCHEMIA
- Condition
- Aneurysmal Subarachnoid Hemorrhage
- Condition
- Delayed Cerebral Ischemia
- Intervention (Drug)
- Nadroparin Injectable Product
- Lead sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Record details
- Record id
cardio:ct-nct04507178- Content hash
a7356c2e6d9089f3a7ca9c779926d39c2218e48893df454da316885451f6eec6